Figure 8.
Mass distribution profile of the aerosol of the optimum EGCG liposome formulation among the NGI stages of the Aeroneb GO nebuliser at a flow rate of 15 L/min. The cut-off diameters was obtained from Marple, et al. [84].
Mass distribution profile of the aerosol of the optimum EGCG liposome formulation among the NGI stages of the Aeroneb GO nebuliser at a flow rate of 15 L/min. The cut-off diameters was obtained from Marple, et al. [84].